AKAP13-NTRK3: A novel NTRK3 oncogenic fusion variant in a patient with melanoma

Oral Oncol. 2020 Dec:111:104891. doi: 10.1016/j.oraloncology.2020.104891. Epub 2020 Jul 9.

Authors

Dongliang Wei¹, Chuang Qi², Yuan Wu², Xing Zhang², Guoxin Ren³

Affiliations

¹ Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, China.
² The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, China.
³ Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, China. Electronic address: [email protected].

PMID: 32654869
DOI: 10.1016/j.oraloncology.2020.104891

No abstract available

Publication types

Case Reports
Letter

MeSH terms

A Kinase Anchor Proteins / genetics*
Female
Gingival Neoplasms / genetics*
Gingival Neoplasms / pathology
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphatic Metastasis
Melanoma / genetics*
Melanoma / pathology
Melanoma / secondary
Middle Aged
Minor Histocompatibility Antigens / genetics*
Neck
Oncogene Fusion / genetics*
Proto-Oncogene Proteins / genetics*
Receptor, trkC / genetics*

Substances

A Kinase Anchor Proteins
AKAP13 protein, human
Minor Histocompatibility Antigens
NTRK3 protein, human
Proto-Oncogene Proteins
Receptor, trkC